The invention provides isolated nucleic acids molecules, designated 2150 nucleic
acid molecules, which encode novel protein kinase family members. The invention
also provides antisense nucleic acid molecules, recombinant expression vectors
containing 2150 nucleic acid molecules, host cells into which the expression vectors
have been introduced, and nonhuman transgenic animals in which a 2150 gene has
been introduced or disrupted. The invention still further provides isolated 2150
proteins, fusion proteins, antigenic peptides and anti-2150 antibodies. Diagnostic
and therapeutic methods utilizing compositions of the invention are also provided.